-
1
-
-
33847023386
-
Ca2 channel subtypes and pharmacology in the kidney
-
Hayashi K, Wakino S, Sugano N, et al. Ca2 channel subtypes and pharmacology in the kidney. Circ Res 2007;100:342-53.
-
(2007)
Circ Res
, vol.100
, pp. 342-353
-
-
Hayashi, K.1
Wakino, S.2
Sugano, N.3
-
2
-
-
33750957976
-
Atherosclerosis-related molecular alteration of the human CaV1 2 calcium channel alpha1C subunit
-
Tiwari S, Zhang Y, Heller J, Abernethy DR, Soldatov NM. Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit. Proc Natl Acad Sci USA 2006;103:17024-9.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 17024-17029
-
-
Tiwari, S.1
Zhang, Y.2
Heller, J.3
Abernethy, D.R.4
Soldatov, N.M.5
-
3
-
-
33645456965
-
Osteoblast Ca(2) permeability and voltage-sensitive Ca(2) channel expression is temporally regulated by 1 25-dihydroxyvitamin D(3)
-
Bergh JJ, Shao Y, Puente E, Duncan RL, Farach-Carson MC. Osteoblast Ca(2) permeability and voltage-sensitive Ca(2) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3). Am J Physiol Cell Physiol 2006;290:C822-C31.
-
(2006)
Am J Physiol Cell Physiol
, vol.290
-
-
Bergh, J.J.1
Shao, Y.2
Puente, E.3
Duncan, R.L.4
Farach-Carson, M.C.5
-
4
-
-
28044471562
-
Pathophysiological significance of T-type Ca2 channels: T-type Ca2 channels and drug development
-
Tanaka H, Shigenobu K. Pathophysiological significance of T-type Ca2 channels: T-type Ca2 channels and drug development. J Pharmacol Sci 2005;99:214-20.
-
(2005)
J Pharmacol Sci
, vol.99
, pp. 214-220
-
-
Tanaka, H.1
Shigenobu, K.2
-
5
-
-
0345490949
-
International Union of pharmacology XL. Compedium of Voltage-Gated Ion Channels: Calcium channels
-
Catterall WA, Striessing J, Terrance P, Snutch P, Perez-Reyes E. International Union of pharmacology. XL. Compedium of Voltage-Gated Ion Channels: Calcium channels. Pharmacol Rev 2003;55:579-81.
-
(2003)
Pharmacol Rev
, vol.55
, pp. 579-581
-
-
Catterall, W.A.1
Striessing, J.2
Terrance, P.3
Snutch, P.4
Perez-Reyes, E.5
-
6
-
-
35748981784
-
A novel Ca(V)1 2 N terminus expressed in smooth muscle cells of resistance size arteries modifies channel regulation by auxiliary subunits
-
Cheng X, Liu J, Asuncion-Chin M, et al. A novel Ca(V)1.2 N terminus expressed in smooth muscle cells of resistance size arteries modifies channel regulation by auxiliary subunits. J Biol Chem 2007;282:29211-21.
-
(2007)
J Biol Chem
, vol.282
, pp. 29211-29221
-
-
Cheng, X.1
Liu, J.2
Asuncion-Chin, M.3
-
9
-
-
42249095978
-
Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension
-
Gojanovic B, Feihl F, Liaudet L, Waeber B. Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. J Renin Angiotensin Aldosterone Syst 2008;9:1-9.
-
(2008)
J Renin Angiotensin Aldosterone Syst
, vol.9
, pp. 1-9
-
-
Gojanovic, B.1
Feihl, F.2
Liaudet, L.3
Waeber, B.4
-
10
-
-
0029927951
-
Disparate effects of calcium antagonists on renal microcirculation
-
Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T. Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res 1996;19:31-6.
-
(1996)
Hypertens Res
, vol.19
, pp. 31-36
-
-
Hayashi, K.1
Nagahama, T.2
Oka, K.3
Epstein, M.4
Saruta, T.5
-
11
-
-
0347423198
-
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
-
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
12
-
-
40449091468
-
The 2007 ESH/ESC guidelines for the management of arterial hypertension
-
Bonny A, Lacombe F, Yitemben M, et al. The 2007 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2008;26:825-6.
-
(2008)
J Hypertens
, vol.26
, pp. 825-826
-
-
Bonny, A.1
Lacombe, F.2
Yitemben, M.3
-
13
-
-
7744231805
-
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial
-
Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004;292:2217-25.
-
(2004)
JAMA
, vol.292
, pp. 2217-2225
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Libby, P.3
-
14
-
-
40149087517
-
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus
-
Fogari R, Derosa G, Zoppi A, et al. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. Hypertens Res 2008;31:43-50.
-
(2008)
Hypertens Res
, vol.31
, pp. 43-50
-
-
Fogari, R.1
Derosa, G.2
Zoppi, A.3
-
15
-
-
77951652189
-
Calcium antagonists: current and future applications based on new evidence Calcium channel blockers and JSH 2009
-
Ebina T, Kimura K, Umemura S. Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and JSH 2009. Clin Calcium 2010;20:16-22.
-
(2010)
Clin Calcium
, vol.20
, pp. 16-22
-
-
Ebina, T.1
Kimura, K.2
Umemura, S.3
-
16
-
-
4444316999
-
Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients
-
Ueshiba H, Miyachi Y. Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients. Intern Med 2004;43:561-5.
-
(2004)
Intern Med
, vol.43
, pp. 561-565
-
-
Ueshiba, H.1
Miyachi, Y.2
-
17
-
-
34548103549
-
Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study
-
Payeras AC, Sladek K, Lembo G, Alberici M. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study. Clin Drug Invest 2007;27:623-32.
-
(2007)
Clin Drug Invest
, vol.27
, pp. 623-632
-
-
Payeras, A.C.1
Sladek, K.2
Lembo, G.3
Alberici, M.4
-
18
-
-
0034821177
-
Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension
-
Zanchetti A, Omboni S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001;38:642-50.
-
(2001)
J Cardiovasc Pharmacol
, vol.38
, pp. 642-650
-
-
Zanchetti, A.1
Omboni, S.2
La Commare, P.3
De Cesaris, R.4
Palatini, P.5
-
19
-
-
54849440849
-
United Kingdom Prospective Diabetes Study (UKPDS): 10 years later
-
Scheen AJ, Paquot N, Lefebvre PJ. United Kingdom Prospective Diabetes Study (UKPDS): 10 years later. Rev Med Liege 2008;63:624-9.
-
(2008)
Rev Med Liege
, vol.63
, pp. 624-629
-
-
Scheen, A.J.1
Paquot, N.2
Lefebvre, P.J.3
-
20
-
-
59149099759
-
The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context
-
Gore MO, McGuire DK. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diab Vasc Dis Res 2009;6:53-5.
-
(2009)
Diab Vasc Dis Res
, vol.6
, pp. 53-55
-
-
Gore, M.O.1
McGuire, D.K.2
-
21
-
-
70349337405
-
Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study
-
Martínez Martín FJ. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study. Expert Review of Cardiovascular Therapy 2009;7:863-9.
-
(2009)
Expert Review of Cardiovascular Therapy
, vol.7
, pp. 863-869
-
-
Martínez Martín, F.J.1
-
22
-
-
72449137809
-
Calcium channel blockers
-
Li CJ, Shi ZD. Calcium channel blockers. Clin Ther 2009;31:1652-63.
-
(2009)
Clin Ther
, vol.31
, pp. 1652-1663
-
-
Li, C.J.1
Shi, Z.D.2
-
23
-
-
70449722295
-
Manidipine prevents hepatic C-reactive protein production and reactive oxygen species generation by down-regulation of the age receptor expression, dependent on PPAR-gamma activation
-
Nakami T, Martinez MFJ. Manidipine prevents hepatic C-reactive protein production and reactive oxygen species generation by down-regulation of the age receptor expression, dependent on PPAR-gamma activation. J Hypertens 2007;25:S119-S20.
-
(2007)
J Hypertens
, vol.25
-
-
Nakami, T.1
Martinez, M.F.J.2
-
24
-
-
0036840307
-
Angiotensin blockade prevents type 2 diabetes by formation of fat cells
-
Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertens 2002;40:609-11.
-
(2002)
Hypertens
, vol.40
, pp. 609-611
-
-
Sharma, A.M.1
Janke, J.2
Gorzelniak, K.3
Engeli, S.4
Luft, F.C.5
-
25
-
-
72649105188
-
Manidipine (but not amlodipine), increases insulin sensitivity and rises plasma adiponectin cocentrations in hypertensive non-diabetic patients with metabolic syndrome and impaired fasting glucose
-
Martínez Martín FJ. Manidipine (but not amlodipine), increases insulin sensitivity and rises plasma adiponectin cocentrations in hypertensive non-diabetic patients with metabolic syndrome and impaired fasting glucose. Diabetologia 2005;48(Suppl 1): A374.
-
(2005)
Diabetologia
, vol.48
, Issue.SUPPL. 1
-
-
Martínez Martín, F.J.1
-
26
-
-
40949124784
-
Effect of delapril/manidipine vs olmesartan/hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients
-
Fogari R, Derosa G, Zoppi A, et al. Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. Intern Med 2008;47:361-6.
-
(2008)
Intern Med
, vol.47
, pp. 361-366
-
-
Fogari, R.1
Derosa, G.2
Zoppi, A.3
-
27
-
-
73449145094
-
Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria
-
Kohlmann O, Jr., Roca-Cusachs A, Laurent S, et al. Fixed-dose manidipine/ delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria. Adv Ther 2009;26:313-24.
-
(2009)
Adv Ther
, vol.26
, pp. 313-324
-
-
Kohlmann Jr., O.1
Roca-Cusachs, A.2
Laurent, S.3
-
28
-
-
66849090315
-
Manidipine has a marked nonhaemodynamic nephroprotective action; Partly dependent on PPAR gamma activation, and synergistic with angiotensin receptor blockade
-
Oshimura H, Nakami T, Javier MF. Manidipine has a marked nonhaemodynamic nephroprotective action; Partly dependent on PPAR gamma activation, and synergistic with angiotensin receptor blockade. J Hypertens 2007;25(Suppl):S8.
-
(2007)
J Hypertens
, vol.25
, Issue.SUPPL.
-
-
Oshimura, H.1
Nakami, T.2
Javier, M.F.3
-
29
-
-
70349246741
-
Cardiometabolic properties of manidipine: beyond lowering arterial pressure?
-
Buset Ríos N, Rodríguez Esparragón F, Rodríguez Pérez J. Cardiometabolic properties of manidipine: beyond lowering arterial pressure?. Nefrologia 2009;29(3):203-7.
-
(2009)
Nefrologia
, vol.29
, Issue.3
, pp. 203-207
-
-
Buset Ríos, N.1
Rodríguez Esparragón, F.2
Rodríguez Pérez, J.3
-
30
-
-
47549088458
-
Inhibition of adipogenesis: a new job for the ER Ca2 pool
-
Meldolesi J. Inhibition of adipogenesis: a new job for the ER Ca2 pool. J Cell Biol 2008;182:11-3.
-
(2008)
J Cell Biol
, vol.182
, pp. 11-13
-
-
Meldolesi, J.1
-
31
-
-
47549114853
-
Calreticulin inhibits commitment to adipocyte differentiation
-
Szabo E, Qiu Y, Baksh S, Michalak M, Opas M. Calreticulin inhibits commitment to adipocyte differentiation. J Cell Biol 2008;182:103-16.
-
(2008)
J Cell Biol
, vol.182
, pp. 103-116
-
-
Szabo, E.1
Qiu, Y.2
Baksh, S.3
Michalak, M.4
Opas, M.5
-
32
-
-
0033852481
-
Preserving renal function in adults with hypertension and diabetes: a consensus approach National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group
-
Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000;36:646-61.
-
(2000)
Am J Kidney Dis
, vol.36
, pp. 646-661
-
-
Bakris, G.L.1
Williams, M.2
Dworkin, L.3
-
33
-
-
20844444291
-
Calcium channel blockers and renal protection: insights from the latest clinical trials
-
Segura J, García-Donaire JA, Ruilope LM. Calcium channel blockers and renal protection: insights from the latest clinical trials. J Am Soc Nephrol 2005;16 (Suppl 1):S64-S6.
-
(2005)
J Am Soc Nephrol
, vol.16
, Issue.SUPPL. 1
-
-
Segura, J.1
García-Donaire, J.A.2
Ruilope, L.M.3
-
34
-
-
0034063529
-
Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats
-
Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000;35:775-9.
-
(2000)
Hypertension
, vol.35
, pp. 775-779
-
-
Sabbatini, M.1
Leonardi, A.2
Testa, R.3
Vitaioli, L.4
Amenta, F.5
-
35
-
-
59049088101
-
Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study
-
Martínez-Martín FJ, Saiz-Satjes M. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study. Expert Review Cardiovascular Therapy 2008;6:1347-55.
-
(2008)
Expert Review Cardiovascular Therapy
, vol.6
, pp. 1347-1355
-
-
Martínez-Martín, F.J.1
Saiz-Satjes, M.2
-
36
-
-
77953527365
-
Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers
-
Galceran J, Plana J, Felip A, et al. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers. Expert Review Cardiovascular Therapy 2010;8:751-7.
-
(2010)
Expert Review Cardiovascular Therapy
, vol.8
, pp. 751-757
-
-
Galceran, J.1
Plana, J.2
Felip, A.3
-
37
-
-
0036434436
-
Role of calcium channel blockers in the future, in view of the INSIGHT Study
-
Rosenthal T. Role of calcium channel blockers in the future, in view of the INSIGHT Study. Kidney Int 2002;82(Suppl):S32-S5.
-
(2002)
Kidney Int
, vol.82
, Issue.SUPPL.
-
-
Rosenthal, T.1
-
38
-
-
9544225173
-
Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) A randomized controlled trial
-
Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 1996;276:785-91.
-
(1996)
JAMA
, vol.276
, pp. 785-791
-
-
Borhani, N.O.1
Mercuri, M.2
Borhani, P.A.3
-
39
-
-
0036668406
-
Effects of calcium channel blockers on atherosclerosis: new insights
-
Simon A, Levenson J. Effects of calcium channel blockers on atherosclerosis: new insights. Acta Cardiol 2002;57:249-55.
-
(2002)
Acta Cardiol
, vol.57
, pp. 249-255
-
-
Simon, A.1
Levenson, J.2
-
40
-
-
0024423885
-
Ion channels and regulation of intracellular calcium in vascular endothelial cells
-
Adams DJ, Barakeh J, Laskey R, Van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989;3:2389-400.
-
(1989)
FASEB J
, vol.3
, pp. 2389-2400
-
-
Adams, D.J.1
Barakeh, J.2
Laskey, R.3
Van Breemen, C.4
-
41
-
-
16244380839
-
Different antioxidative potencies of dihydropyridine calcium channel modulators in various models
-
Berkels R, Breitenbach T, Bartels H, et al. Different antioxidative potencies of dihydropyridine calcium channel modulators in various models. Vasc Pharmacol 2005;42:145-52.
-
(2005)
Vasc Pharmacol
, vol.42
, pp. 145-152
-
-
Berkels, R.1
Breitenbach, T.2
Bartels, H.3
-
42
-
-
27744458898
-
Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine
-
Toba H, Nakagawa Y, Miki S, et al. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Hypertens Res 2005;28:689-700.
-
(2005)
Hypertens Res
, vol.28
, pp. 689-700
-
-
Toba, H.1
Nakagawa, Y.2
Miki, S.3
-
43
-
-
33645834145
-
Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells
-
Toba H, Shimizu T, Miki S, et al. Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells. Hypertens Res 2006;29:105-16.
-
(2006)
Hypertens Res
, vol.29
, pp. 105-116
-
-
Toba, H.1
Shimizu, T.2
Miki, S.3
-
44
-
-
43649084568
-
Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk
-
Sun X, Zemel MB. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem 2008;19:392-9.
-
(2008)
J Nutr Biochem
, vol.19
, pp. 392-399
-
-
Sun, X.1
Zemel, M.B.2
-
45
-
-
77954143701
-
Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages
-
Costa S, Zimetti F, Pedrelli M, Cremonesi G, Bernini F. Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages. Pharmacol Res 2010;62:265-70.
-
(2010)
Pharmacol Res
, vol.62
, pp. 265-270
-
-
Costa, S.1
Zimetti, F.2
Pedrelli, M.3
Cremonesi, G.4
Bernini, F.5
-
46
-
-
33644848062
-
Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1
-
Moosmang S, Haider N, Bruderl B, Welling A, Hofmann F. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2. Circ Res 2006;98:105-10.
-
(2006)
2. Circ Res
, vol.98
, pp. 105-110
-
-
Moosmang, S.1
Haider, N.2
Bruderl, B.3
Welling, A.4
Hofmann, F.5
-
47
-
-
68849128065
-
Calcium and calmodulin regulate mercury-induced phospholipase D activation in vascular endothelial cells
-
Peltz A, Sherwani SI, Kotha SR, et al. Calcium and calmodulin regulate mercury-induced phospholipase D activation in vascular endothelial cells. Int J Toxicol 2009;28:190-206.
-
(2009)
Int J Toxicol
, vol.28
, pp. 190-206
-
-
Peltz, A.1
Sherwani, S.I.2
Kotha, S.R.3
-
48
-
-
45949112649
-
Calcium channel-blockers for managing metabolic syndrome-associated hypertension
-
Martínez Martín FJ. Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine. Nefrologia 2007;27 (Suppl 6):26-35.
-
(2007)
Trials with manidipine. Nefrologia
, vol.27
, Issue.SUPPL. 6
, pp. 26-35
-
-
Martínez Martín, F.J.1
-
49
-
-
70349311365
-
Mechanisms of potentiation of Angiotensin II-induced contractile response of isolated rat aorta by hydrogen peroxide and tert-butyryl hydroperoxide
-
Patel RJ, Patel PD, Patel MM, Patel NJ, Thyagarajan B. Mechanisms of potentiation of Angiotensin II-induced contractile response of isolated rat aorta by hydrogen peroxide and tert-butyryl hydroperoxide. Indian J Pharmacol 2009;41:140-3.
-
(2009)
Indian J Pharmacol
, vol.41
, pp. 140-143
-
-
Patel, R.J.1
Patel, P.D.2
Patel, M.M.3
Patel, N.J.4
Thyagarajan, B.5
-
50
-
-
77954966895
-
Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients
-
Nakano N, Ishimitsu T, Takahashi T, et al. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients. Int Heart J 2010;51:188-92.
-
(2010)
Int Heart J
, vol.51
, pp. 188-192
-
-
Nakano, N.1
Ishimitsu, T.2
Takahashi, T.3
|